Swedish Orphan Biovitrum AB (publ) (STO:SOBI)
Sweden · Delayed Price · Currency is SEK 373.40
+11.20 (3.09%)
Mar 25, 2026, 3:15 PM CET
STO:SOBI Market Cap
STO:SOBI has a market cap or net worth of 125.2 billion as of March 25, 2026. Its market cap has increased by 19.45% in one year.
Market Cap
125.20B
Enterprise Value
135.66B
Revenue
28.24B
Ranking
n/a
PE Ratio
264.38
Stock Price
373.40
Market Cap Chart
Since September 15, 2006, STO:SOBI's market cap has increased from 4.83B to 125.20B, an increase of 2,493.04%. That is a compound annual growth rate of 18.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 125.20B | 9.15% |
| Dec 30, 2025 | 114.70B | 4.06% |
| Dec 30, 2024 | 110.22B | 20.19% |
| Dec 29, 2023 | 91.70B | 41.80% |
| Dec 30, 2022 | 64.67B | 16.86% |
| Dec 30, 2021 | 55.34B | 12.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGaia AB | 11.33B |
| Cereno Scientific AB | 1.95B |
| EQL Pharma AB | 1.55B |
| Dicot Pharma AB | 844.93M |
| Cinclus Pharma Holding AB | 833.03M |
| Orexo AB | 788.60M |
| Nanexa AB | 625.42M |
| Enzymatica AB | 553.44M |